Diisopropylfluorphosphorsaeureester en es it fr

Diisopropylfluorphosphorsaeureester Brand names, Diisopropylfluorphosphorsaeureester Analogs

Diisopropylfluorphosphorsaeureester Brand Names Mixture

  • No information avaliable

Diisopropylfluorphosphorsaeureester Chemical_Formula


Diisopropylfluorphosphorsaeureester RX_link

No information avaliable

Diisopropylfluorphosphorsaeureester fda sheet

Diisopropylfluorphosphorsaeureester msds (material safety sheet)

Diisopropylfluorphosphorsaeureester MSDS

Diisopropylfluorphosphorsaeureester Synthesis Reference

No information avaliable

Diisopropylfluorphosphorsaeureester Molecular Weight

184.146 g/mol

Diisopropylfluorphosphorsaeureester Melting Point

-82 oC

Diisopropylfluorphosphorsaeureester H2O Solubility

1.54E+004 mg/L

Diisopropylfluorphosphorsaeureester State


Diisopropylfluorphosphorsaeureester LogP


Diisopropylfluorphosphorsaeureester Dosage Forms

No information avaliable

Diisopropylfluorphosphorsaeureester Indication

For use in the eye to treat certain types of glaucoma and other eye conditions, such as accommodative esotropia.

Diisopropylfluorphosphorsaeureester Pharmacology

Isoflurophate is used as ocular drops in the treatment of chronic glaucoma. Isoflurophate is an organophosphorus compound that acts as an irreversible cholinesterase inhibitor. As such, it displays parasympathomimetic effects. Isoflurophate is used in the eye to treat certain types of glaucoma and other eye conditions, such as accommodative esotropia. They may also be used in the diagnosis of certain eye conditions, such as accommodative esotropia. Isoflurophate damages the acetylcholinesterase enzyme and is therefore irreversible, however, pralidoxime can displace organophosphates such as isoflurophate from acetylcholinesterase, but only if administered before isoflurophate damages (alkylates) the enzyme.

Diisopropylfluorphosphorsaeureester Absorption

No information avaliable

Diisopropylfluorphosphorsaeureester side effects and Toxicity

Signs of overdose include increased sweating, loss of bladder control, muscle weakness, nausea, vomiting, diarrhea, or stomach cramps or pain, shortness of breath, tightness in chest, or wheezing, slow or irregular heartbeat, unusual tiredness or weakness, watering of mouth.

Diisopropylfluorphosphorsaeureester Patient Information

No information avaliable

Diisopropylfluorphosphorsaeureester Organisms Affected

Humans and other mammals